HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 164 filers reported holding HEALTH CATALYST INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,338,833 | +50.8% | 1,120,438 | +86.3% | 0.01% | +66.7% |
| Q2 2023 | $7,517,925 | +9.1% | 601,434 | +1.9% | 0.01% | 0.0% |
| Q1 2023 | $6,889,198 | +37.5% | 590,334 | +25.2% | 0.01% | +20.0% |
| Q4 2022 | $5,010,280 | +9.4% | 471,334 | -0.2% | 0.01% | +25.0% |
| Q3 2022 | $4,581,000 | +3.2% | 472,244 | +54.2% | 0.00% | 0.0% |
| Q2 2022 | $4,437,000 | -37.5% | 306,244 | +12.8% | 0.00% | -20.0% |
| Q1 2022 | $7,095,000 | -25.5% | 271,527 | +13.0% | 0.01% | -28.6% |
| Q4 2021 | $9,518,000 | -18.3% | 240,244 | +3.1% | 0.01% | -12.5% |
| Q3 2021 | $11,648,000 | -9.9% | 232,909 | -0.0% | 0.01% | -11.1% |
| Q2 2021 | $12,935,000 | +24.6% | 233,015 | +5.0% | 0.01% | +28.6% |
| Q1 2021 | $10,384,000 | +136.4% | 222,015 | +120.0% | 0.01% | +133.3% |
| Q4 2020 | $4,393,000 | +84.9% | 100,909 | +55.5% | 0.00% | +50.0% |
| Q3 2020 | $2,376,000 | +81.4% | 64,909 | +44.5% | 0.00% | +100.0% |
| Q2 2020 | $1,310,000 | – | 44,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Norwest Venture Partners XI, LP | 876,045 | $32,063,000 | 100.00% |
| Norwest Venture Partners XII, LP | 876,045 | $32,063,000 | 69.68% |
| Nepsis Inc. | 197,178 | $7,217,000 | 3.46% |
| Karani Asset Management LLC | 133,968 | $4,903,000 | 3.29% |
| ADAMS STREET PARTNERS LLC | 201,548 | $6,639,000 | 1.75% |
| HHR Asset Management, LLC | 412,423 | $15,095,000 | 1.50% |
| Mesirow Financial Investment Management, Inc. | 9,510 | $348,000 | 1.49% |
| ASHFORD CAPITAL MANAGEMENT INC | 342,500 | $12,536,000 | 1.49% |
| Roubaix Capital, LLC | 31,889 | $1,167,000 | 1.38% |
| Monarch Partners Asset Management LLC | 154,847 | $5,667,000 | 1.28% |